References
- Barceloux DG. (1999). Cobalt. Clin Toxicol 37:201–16
- Domínguez-Vera JM. (2004). Iron (III) complexation of Desferrioxamine B encapsulated in apoferritin. J Inorg Biochem 98:469–72
- Fatemi SJ, Amiri A, Bazargan MH, et al. (2007). Clinical evaluation of desferrioxamine (DFO) for removal of thallium ions in rat. Int J Artif Organs 30:902–5
- Fatemi SJ, Shokooh Saljooghi A, Dahooee Balooch F, et al. (2011). Chelation of cadmium by combining deferasirox and deferiprone in rats. Toxicol Ind Health 27:371–7
- Finley BL, Monnot AD, Paustenbach DJ, Gaffney ShH. (2007). Derivation of a chronic oral reference dose for cobalt. Regul Toxicol Pharmacol 64:491–503
- Fukuda S. (2005). Chelating agents used for plutonium and uranium removal in radiation emergency medicine. Curr Med Chem 12:2765–70
- Galbraith RA, Kappas A. (1989). Regulation of food intake and body weight by cobalt portphyrins in animals. Proc Natl Acad Sci USA 86:7653–7
- Gross RT, Kriss JP, Spaet TH. (1955). The hematopoietic and goitrogenic effects of cobaltous chloride in patients with sickle cell anemia. Pediatrics 15:284–90
- Heinz U, Hegetschweiler K, Acklin P, et al. (1999). 4-[3,5-Bis (2-hydroxyphenyl)- 1,2,4-triazol-1-yl]-benzoic acid: a novel, efficient and selective iron (iii) complexing agent. Angew Chem Int Ed 38:2568–71
- Klaassen CD. (1986). Casarett and Doull’s toxicology the basic science of poisoning, 6th ed. New York: McGraw-Hill, Medical Publishing Division, 839
- Lauwerys R, Lison D. (1994). Health risks associated with cobalt exposure. An overview. Sci Total Environ 150:1–6
- Leggett RW. (2008). The biokinetics of inorganic cobalt in the human body. Sci Total Environ 389:259–69
- Lippi G, Franchini M, Guidi GC. (2006). Blood doping by cobalt. Should we measure cobalt in athletes? J Occup Med Toxicol 1:18–9
- Neve J. (1991). The nutritional importance and pharmacologic effects of cobalt and vitamin B12 sub in man. J Pharm Belg 46:271–80
- Seghizzi P, D’Adda F, Borleri D, et al. (1994). Cobalt myocardiopathy: a critical review of literature. Sci Total Environ 150:105–9
- Shokooh Saljooghi A, Fatemi SJ. (2011). Removal of thallium by deferasirox in rats as biological model. J Appl Toxicol 31:139–43
- Shokooh Saljooghi A, Fatemi SJ. (2010). Clinical evaluation of deferasirox for removal of cadmium ions in rat. Biometals 23:707–12
- Singh S, Epemolu O, Dobbin PS, et al. (1992). Urinary metabolic profile in human and rat of 1,2-dimethyl and 1,2-diethyl substituted 3-hydroxypyridin-4-ones. Drug Metab Dispos 20:256–61
- Tubafard S, Fatemi SJ, Shokooh Saljiighi A, Torkzadeh M. (2010). Removal of vanadium by combining desferrioxamine and deferiprone chelatores in rats. Med Chem Res 19:854–63
- Tubafard S, Fatemi SJ. (2008). Chelation of bismuth by combining desferrioxamine and deferiprone in rats. Toxicol Ind Health 24:235–40
- World Health Organization (WHO). (2006). Cobalt and inorganic cobalt compounds. Concise International Chemical Assessment Document 69. World Health Organization. Geneva, Switzerland: WHO Press